Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zahangir Khaled

Pediatric Gastroenterology Springfield, IL Medical Doctor

NPI 1356316715 CMS profile 242568

301 N 8Th St, Suite Pav 4A, Springfield, IL 62701

Open in the dashboard

General payments

$3,025

72 records reported · program years 2019–2025

Research payments

$550

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$50,018 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Zahangir Khaled of Springfield, IL is reported in the CMS Open Payments database as having received $3,025 across 72 general payments and $550 in research payments paid to them. Separately, studies naming them as principal investigator received $50,018 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 81st percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $243 9
2024 General $1,892 24
2023 General $415 17
2022 General $104 5
2022 Research $550 1
2021 General $230 9
2020 General $39 2
2019 General $101 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zahangir Khaled
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Zahangir Khaled were reported at $243. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Zahangir Khaled Pediatric Gastroenterology median Middle half National median
2019 $101 $131 $41–$311 $163
2020 $39 $79 $23–$223 $114
2021 $230 $104 $32–$321 $132
2022 $104 $125 $37–$331 $149
2023 $415 $169 $55–$440 $160
2024 $1,892 $196 $73–$563 $164
2025 $243 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $1,769 18 payments
  2. Regeneron Healthcare Solutions, Inc. $456 19 payments
  3. AbbVie, Inc. $323 9 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $181 10 payments
  5. Merck Sharp & Dohme Corporation $66 4 payments
  6. Mirum Pharmaceuticals, Inc. $42 2 payments
  7. Shire North American Group Inc $36 2 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $30 2 payments
  9. Janssen Biotech, Inc. $23 1 payment
  10. Braintree Laboratories, Inc. $22 1 payment
  11. Other $77 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,615 70 payments
  2. Consulting Fee $1,396 1 payment
  3. Education $14 1 payment
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $1,769 18 payments
  2. DUPIXENT Inflammation And Immunology $388 17 payments
  3. HUMIRA $145 4 payments
  4. GATTEX $116 6 payments
  5. DUPIXENT Immunology And Inflammation $68 2 payments
  6. RENFLEXIS $66 4 payments
  7. RINVOQ $64 2 payments
  8. SKYRIZI $57 1 payment
  9. LINZESS $56 2 payments
  10. Livmarli $42 2 payments
  11. Other $288 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $550 1 payment

Billing to Medicare

Part B · data year 2024 · 3 billing codes

Paid by Medicare

$1,016

Medicare's payments for the services billed

Medicare patients

19

Average age 73

Services billed

23

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Cancer 0%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DUPIXENT
  • GENZYME CORPORATION $1,495
  • Regeneron Healthcare Solutions, Inc. $185
$1,679 — —
SKYRIZI
  • AbbVie, Inc. $57
$57 — —
EOHILIA
  • Takeda Pharmaceuticals U.S.A., Inc. $33
$33 — —
RINVOQ
  • AbbVie, Inc. $31
$31 — —
CYLTEZO
  • Boehringer Ingelheim Pharmaceuticals, Inc. $30
$30 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

73 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record